fda pulling semaglutide warns dangers of using ‘off brand’ weight loss drugs UT San Antonio study: As

p = 0.07), indicating a large level of disparity between the two treatments (Figure 3)

The medication also carries warnings involving pancreatitis, diabetic retinopathy complications, acute kidney injury due to volume depletion, severe gastrointestinal adverse reactions, gallbladder disease, and other safety considerations

Compounded semaglutide typically remains stable for approximately 30 days when stored unopened in refrigerated conditions (2-8C)

Dietary changes : Patients starting GLP-1 therapy often make significant dietary modifications, including increased vegetable and fruit consumption (which have high water content) and reduced processed food intake